mdjbrown, I checked the couch for any spare loose change andhere's why. Pidduck showed a great deal of confidence in this recent conference call to disclose that they and their pharma partner are waiting for FDA approval for a generic version of Epidiolex. He then drops a clue big enough to figure it out quite easily w.r.t. to one of Brazil's largest generic makers having recently completed an acquisition....late September closing a deal by Eurofarm puts them as the strongest candidate. Eurofarm covering all of South America as well as activity in the U.S. and Europe as a generic drug maker. It doesn't take long to connect the dots that for South America, Brazil, ANVISA pending approval that it too is probably for a generic version of Epidiolex as well.
In summary, based on those disclosures made during the last CC I personally take it as a strong level of confidence from Pidduck AND therefore we are in the zone of MAJOR NEWS PENDING!!!